Drug Database
Back to search

Japan· JP-2149020N1031

ウラピジル

A urapidil product containing ウラピジル, registered in Japan by 科研製薬, on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.

On Japan’s NHI price listATC C02CA06

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedウラピジルATCC02CA06REGISTER NO.JP-2149020N1031PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ウラピジルAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Urapidil is registered in 10 of 19 countries.

Countries holding a registration under ATC C02CA06 (urapidil), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 6 of them publish a price we can compare per daily dose
Search urapidil products by name

Urapidil · ATC C02CA06

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Franceprice
  • Germany
  • Japan
  • Netherlands
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
ウラピジル
Manufacturer
科研製薬
Country
Japan (JP)
ATC code
C02CA06
ATC class
Urapidil
Defined daily dose
0.12 g, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under C02CA06

Urapidil, as other registers publish it.

All urapidil products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c104dbb0-7e63-4cf9-b42e-91c15b6cf3f6
GET /v1/drugs/c104dbb0-7e63-4cf9-b42e-91c15b6cf3f6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "１５ｍｇ１カプセル",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "2149020N1031",
  "category": "内用薬",
  "price_yen": 15.8,
  "generic_name": "ウラピジル",
  "product_name_jp": null,
  "therapeutic_class": "2149",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about urapidil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console